BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalCancers
Volume14
StatePublished - Jan 1 2022

Cite this